• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, November 8, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Trojan Horse: How a killer fungus unleashes meningitis and brain infection

Bioengineer by Bioengineer
June 18, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Published today in The American Journal of Pathology, the study was led by a team from the Westmead Institute for Medical Research and the Marie Bashir Institute for Infectious Disease and Biosecurity of the University of Sydney.

Meningitis is an inflammation of the meninges, the three membranes that cover the brain and spinal cord. Meningitis can occur when fluid that bathes the brain and separates it from the meninges becomes infected.

Researchers identified a two-step invasion process mediated by the immune system, which, while being the body's primary defence against Cryptococcus infection, paradoxically promotes infection and meningitis.

The team observed the specific location where circulating white blood cells, known as monocytes, act as transport vehicles for cryptococci to cross from small blood vessels (post-capillary venues or PVCs) in and around the brain into the peri-vascular space outside these blood vessels.

They also observed cryptococci released from monocytes into this peri-vascular space then separately enter the brain, causing tumour-like lesions and the fluid surrounding the brain to cause meningitis.

Key findings

Lead researcher, Professor Tania Sorrell from the University of Sydney, said: "We have shown for the first time that the early immune response in neurocryptococcosis is comprised of white blood cells called monocytes, neutrophils and lymphocytes, recruited from the blood across the endothelial lining of PCVs into the adjacent peri-vascular space.

"We also show that blood-derived monocytes and, to a lesser extent, neutrophils, by acting as Trojan horses, are the major effectors of Cryptococcus neoformans invasion of the central nervous system, by the same route."

The discovery is an important first step for designing new treatments that could prevent and treat infection by the killer fungus, Professor Sorrell notes.

"Understanding this complex process is an important first step in designing new types of treatments that could complement the use of antifungal drugs.

Cryptococcus neoformans is a fungus that lives in the environment throughout the world, notes The Centers for Disease Control and Prevention. It is typically found in soil, on decaying wood, in tree hollows, or in bird droppings.

Cryptococcus neoformans is a common cause of meningitis that kills up to a third of patients even when treated appropriately.

Worldwide, an estimated 220,000 new cases of cryptococcal meningitis occur each year, resulting in 181,000 deaths.

People can become infected after breathing in the microscopic fungus, although most people who are exposed to the fungus never get sick from it.

Cryptococcus neoformans infections are rare in people who are otherwise healthy. Most cases occur in people who have weakened immune systems, particularly those who have advanced HIV/AIDS.

###

Media Contact

Dan Gaffney
[email protected]
61-481-004-782
@SydneyUni_Media

http://www.usyd.edu.au/

Share12Tweet7Share2ShareShareShare1

Related Posts

Facial Recognition Challenges in Children With Prosopagnosia

November 8, 2025

Korean Medicine’s Approach to Asthma: A Survey

November 8, 2025

Exploring Food Addiction: Psychology, Self-Control, and Eating

November 8, 2025

Prenatal Vitamin D and Child Respiratory Health: Review

November 8, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    314 shares
    Share 126 Tweet 79
  • ESMO 2025: mRNA COVID Vaccines Enhance Efficacy of Cancer Immunotherapy

    206 shares
    Share 82 Tweet 52
  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1302 shares
    Share 520 Tweet 325
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    139 shares
    Share 56 Tweet 35

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Empagliflozin Protects Mice from Doxorubicin Liver Damage

Facial Recognition Challenges in Children With Prosopagnosia

Tβ4–17 Boosts Ovarian Cancer Chemo-Sensitivity via NF-κB

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.